PL1929047T3 - Sposoby i kompozycje do szczepienia zwierząt antygenami PRRSV o ulepszonej immunogenności - Google Patents
Sposoby i kompozycje do szczepienia zwierząt antygenami PRRSV o ulepszonej immunogennościInfo
- Publication number
- PL1929047T3 PL1929047T3 PL06824866T PL06824866T PL1929047T3 PL 1929047 T3 PL1929047 T3 PL 1929047T3 PL 06824866 T PL06824866 T PL 06824866T PL 06824866 T PL06824866 T PL 06824866T PL 1929047 T3 PL1929047 T3 PL 1929047T3
- Authority
- PL
- Poland
- Prior art keywords
- prrsv
- methods
- pigs
- compositions
- vaccination
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000005847 immunogenicity Effects 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 abstract 3
- 241000282887 Suidae Species 0.000 abstract 3
- 102000018697 Membrane Proteins Human genes 0.000 abstract 2
- 108010052285 Membrane Proteins Proteins 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71235705P | 2005-08-30 | 2005-08-30 | |
| EP06824866A EP1929047B1 (en) | 2005-08-30 | 2006-08-30 | Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity |
| PCT/US2006/033990 WO2007040876A2 (en) | 2005-08-30 | 2006-08-30 | Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1929047T3 true PL1929047T3 (pl) | 2010-08-31 |
Family
ID=37906634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06824866T PL1929047T3 (pl) | 2005-08-30 | 2006-08-30 | Sposoby i kompozycje do szczepienia zwierząt antygenami PRRSV o ulepszonej immunogenności |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7608272B2 (pl) |
| EP (1) | EP1929047B1 (pl) |
| JP (1) | JP2009506129A (pl) |
| KR (1) | KR20080064813A (pl) |
| CN (1) | CN101300363A (pl) |
| AT (1) | ATE461295T1 (pl) |
| BR (1) | BRPI0615610A2 (pl) |
| CA (1) | CA2620667A1 (pl) |
| DE (1) | DE602006013003D1 (pl) |
| DK (1) | DK1929047T3 (pl) |
| ES (1) | ES2343371T3 (pl) |
| PL (1) | PL1929047T3 (pl) |
| WO (1) | WO2007040876A2 (pl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7622254B2 (en) * | 2005-11-29 | 2009-11-24 | Iowa State University Research Foundation, Inc. | Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof |
| EP1792996A1 (en) * | 2005-12-01 | 2007-06-06 | Consejo Superior de Investigaciones Cientificas | Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV) |
| US9717788B2 (en) | 2007-03-02 | 2017-08-01 | Glaxosmithkline Biologicals Sa | Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant |
| TW200914043A (en) * | 2007-04-30 | 2009-04-01 | Mj Biolog Inc | PRRSV GP5 based compositions and methods |
| KR101101386B1 (ko) * | 2008-12-04 | 2012-01-02 | 주식회사 바이오리쏘스 | 북미형 ｐｒｒｓｖ에 특이적인 면역원성 펩티드 및 그의 용도 |
| BRPI1009454A2 (pt) * | 2009-03-10 | 2019-09-24 | Baylor Res Institute | vacinas contra o câncer direcionadas a células apresentadoras de antígenos |
| CN108373509A (zh) | 2009-03-10 | 2018-08-07 | 贝勒研究院 | 靶向抗原呈递细胞的抗病毒疫苗 |
| BRPI1009455A2 (pt) | 2009-03-10 | 2016-03-01 | Baylor Res Inst | anticorpos anti-c40 e usos dos mesmos |
| TWI391487B (zh) * | 2010-05-04 | 2013-04-01 | Univ Nat Taiwan | 以植物生產之豬生殖與呼吸道綜合症口服疫苗及其用途 |
| UA108902C2 (uk) * | 2010-11-10 | 2015-06-25 | Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування | |
| US10160789B2 (en) * | 2011-03-14 | 2018-12-25 | University Of Louisville Research Foundation, Inc. | Polypeptides having immunoactivating activity and methods of producing the same |
| US20120301465A1 (en) | 2011-03-25 | 2012-11-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compositions and methods to immunize against hepatitis c virus |
| JP6101251B2 (ja) | 2011-05-07 | 2017-03-22 | ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィーLaboratorio Avi−Mex, S.A. De C.V. | ウイルスベクターにおける抗ｐｒｒｓ組換えワクチン |
| KR101420850B1 (ko) * | 2011-05-30 | 2014-08-13 | 건국대학교 산학협력단 | 돼지 생식기 호흡기 증후군 바이러스 유사입자 및 이를 이용한 백신 |
| ES2674439T3 (es) * | 2011-06-01 | 2018-06-29 | Merial, Inc. | Administración sin aguja de vacunas contra el VSRRP |
| CN102559611B (zh) * | 2011-06-23 | 2015-04-22 | 江苏省农业科学院 | 一种无筛选标记的双表达重组mva病毒及其构建方法 |
| CN102351952B (zh) * | 2011-10-19 | 2015-07-01 | 中国医学科学院基础医学研究所 | 一种低糖化突变体干扰素-λ1、其表达、纯化方法及其应用 |
| US8906385B2 (en) | 2011-12-01 | 2014-12-09 | University Of Maryland, College Park | Interferon-inducing porcine reproductive and respiratory syndrome virus isolate |
| WO2015106281A1 (en) | 2014-01-13 | 2015-07-16 | Baylor Research Institute | Novel vaccines against hpv and hpv-related diseases |
| WO2015140774A1 (en) | 2014-03-21 | 2015-09-24 | Nutech Ventures | A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using |
| TWI554609B (zh) * | 2014-11-19 | 2016-10-21 | 國立屏東科技大學 | 抗豬生殖與呼吸綜合症病毒感染之重組融合抗原基因、重組融合抗原蛋白及含彼之次單位疫苗組成物 |
| US10758605B2 (en) | 2015-06-29 | 2020-09-01 | University Of Louisville Research Foundation, Inc. | Compositions and methods for treating cancer and promoting wound healing |
| CN105400745B (zh) * | 2015-12-04 | 2018-11-13 | 南京农业大学 | 一种猪繁殖与呼吸综合征病毒基因工程毒株及其灭活疫苗和疫苗制备方法 |
| CN106177945A (zh) * | 2016-08-25 | 2016-12-07 | 芜湖英特菲尔生物制品产业研究院有限公司 | 一种猪疫苗用免疫增强剂、其制备方法及应用 |
| CN107653254B (zh) * | 2017-09-22 | 2020-12-25 | 龙岩学院 | 一种猪繁殖与呼吸综合症病毒重组orf5基因及其制备方法 |
| US10610585B2 (en) | 2017-09-26 | 2020-04-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and compositions for treating and preventing HIV |
| WO2020138761A1 (ko) * | 2018-12-27 | 2020-07-02 | 주식회사 바이오포아 | 돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신 |
| KR102335864B1 (ko) * | 2018-12-27 | 2021-12-06 | 주식회사 바이오포아 | 돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신 |
| US12343375B2 (en) | 2021-02-09 | 2025-07-01 | University Of Louisville Research Foundation, Inc. | Spray dried formulation of a cholera toxin B subunit variant |
| KR102753517B1 (ko) * | 2021-12-30 | 2025-01-10 | 주식회사 바이오포아 | 돼지생식기호흡기증후군바이러스 유래 펩타이드 (ep8)을 발현하는 키메라 바이러스 및 이를 포함하는 백신 조성물 |
| CN116064960A (zh) * | 2022-11-10 | 2023-05-05 | 上海海关动植物与食品检验检疫技术中心 | 用于prrsv谱系1c变异株荧光rt-pcr检测的引物探针组、试剂盒及其检测方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| NZ513289A (en) | 1998-12-22 | 2003-04-29 | Pfizer Prod Inc | Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| JP3961222B2 (ja) * | 1999-03-08 | 2007-08-22 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | Ｐｒｒｓｖワクチン |
| EP1350840B1 (en) * | 2002-04-05 | 2012-05-09 | Boehringer Ingelheim Vetmedica GmbH | Adaptation sites of PRRSV |
-
2006
- 2006-08-30 PL PL06824866T patent/PL1929047T3/pl unknown
- 2006-08-30 KR KR1020087007613A patent/KR20080064813A/ko not_active Withdrawn
- 2006-08-30 ES ES06824866T patent/ES2343371T3/es active Active
- 2006-08-30 CA CA002620667A patent/CA2620667A1/en not_active Abandoned
- 2006-08-30 US US12/064,877 patent/US7608272B2/en active Active
- 2006-08-30 DK DK06824866.5T patent/DK1929047T3/da active
- 2006-08-30 EP EP06824866A patent/EP1929047B1/en not_active Not-in-force
- 2006-08-30 BR BRPI0615610-0A patent/BRPI0615610A2/pt not_active Application Discontinuation
- 2006-08-30 DE DE602006013003T patent/DE602006013003D1/de active Active
- 2006-08-30 AT AT06824866T patent/ATE461295T1/de not_active IP Right Cessation
- 2006-08-30 WO PCT/US2006/033990 patent/WO2007040876A2/en not_active Ceased
- 2006-08-30 JP JP2008529267A patent/JP2009506129A/ja active Pending
- 2006-08-30 CN CNA2006800405321A patent/CN101300363A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007040876A3 (en) | 2007-06-07 |
| EP1929047A2 (en) | 2008-06-11 |
| JP2009506129A (ja) | 2009-02-12 |
| EP1929047A4 (en) | 2009-05-06 |
| US20080233083A1 (en) | 2008-09-25 |
| ES2343371T3 (es) | 2010-07-29 |
| BRPI0615610A2 (pt) | 2011-05-24 |
| EP1929047B1 (en) | 2010-03-17 |
| CA2620667A1 (en) | 2007-04-12 |
| KR20080064813A (ko) | 2008-07-09 |
| DE602006013003D1 (de) | 2010-04-29 |
| DK1929047T3 (da) | 2010-07-12 |
| CN101300363A (zh) | 2008-11-05 |
| US7608272B2 (en) | 2009-10-27 |
| ATE461295T1 (de) | 2010-04-15 |
| WO2007040876A2 (en) | 2007-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007040876A3 (en) | Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity | |
| WO2007081447A3 (en) | Norovirus and sapovirus antigens | |
| CY1112572T1 (el) | Εμβολια γριπης που περιλαμβανουν συνδυασμους σωματιδιακων ανοσοενισχυτικων και ανοσοδιεγερτες | |
| MX2019008303A (es) | Ácido ribonucleico modificado con nucleósidos para inducir una respuesta inmune contra el virus zika. | |
| BRPI1015917A2 (pt) | antígenos de rsv recombinantes. | |
| IL184845A0 (en) | Chimeric recombinant antigens of toxoplasma gondii | |
| DK1898948T3 (da) | Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans | |
| IN2009CN03372A (pl) | ||
| WO2008057235A3 (en) | Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes | |
| WO2009154995A3 (en) | Interleukin 10 receptor (il-10r) antibodies and methods of use | |
| AR095482A1 (es) | Virus del síndrome reproductivo y respiratorio porcino, composiciones, vacuna y métodos de uso | |
| WO2007098717A3 (es) | Antígenos vacunales quiméricos contra el virus de la peste porcina clásica | |
| WO2005120565A8 (en) | Sars vaccines and methods to produce highly potent antibodies | |
| EA200970262A1 (ru) | Композиции и способы, относящиеся к антителам к глюкагоновым рецепторам | |
| WO2007098718A8 (es) | Antígenos vacunales quiméricos contra el virus de la influenza aviar | |
| CY1112575T1 (el) | Βελτιωμενα αδρανοποιημενα εμβολια fcv | |
| NZ704188A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
| WO2007008527A3 (en) | Chimeric vaccine for haemophilus influenzae-induced disease | |
| WO2006136460A8 (en) | New adjuvant | |
| AU2001284354A1 (en) | Immunological adjuvant compounds, compositions, and methods of use thereof | |
| Marcos et al. | Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus | |
| TNSN08184A1 (en) | Chimeric antigens and vaccines | |
| MX2009000717A (es) | Composicion para vacuna y metodo para inmunizacion. | |
| WO2005077412A3 (en) | Compositions and methods of use of w-peptides | |
| WO2004043286A3 (en) | Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen |